Trial Profile
Clinical Trials Insight: 700049013
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 20 Sep 2009
Price :
$35
*
At a glance
- Drugs ISIS 104838 (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Ionis Pharmaceuticals